Zellweger syndrome knockout mouse models challenge putative peroxisomal β-oxidation involvement in docosahexaenoic acid (22:6n-3) biosynthesis

被引:21
作者
Infante, JP [1 ]
Huszagh, VA [1 ]
机构
[1] Inst Theoret Biochem & Mol Biol, Ithaca, NY 14852 USA
关键词
peroxisomes; mitochondria; carnitine; desaturase; hepatomegaly; neuronal migration; hypotonia; craniofacial dysmorphisms; mental retardation; myelin;
D O I
10.1006/mgme.2000.3101
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The putative involvement of peroxisomal beta -oxidation in the biosynthetic pathway of docosahexaenoic acid (22:6n-3, DHA) synthesis is critically reviewed in light of experiments with two recently developed knockout mouse models for Zellweger syndrome, a peroxisomal disorder affecting brain development. These mice were generated by targeted disruption of the PEX2 and PEX5 peroxisomal assembly genes encoding targeting signal receptor peroxins for the recognition and transport of a set of peroxisomal enzymes, including those of peroxisomal p-oxidation, to the peroxisomal matrix. Analysis of esterified 22:6n-3 concentrations in PEX2(-/-) and PEX5(-/-) mice do not support the hypothesized requirement of peroxisomal beta -oxidation in 22:6n-3 synthesis, as only brain, but not liver or plasma, 22:6n-3 levels were decreased. Supplementation of PEX5(+/-) darns with 22:6n-3, although restoring the levels of brain 22:6n-3 in total lipids to that of controls, did not normalize the phenotype. These decreased brain 22:6n-3 concentrations appear to be secondary to impaired plasmalogen (sn-1-alkyl-, alkenyl-2-acyl glycerophospholipids) synthesis, probably at the level of the dihydroxyacetonephosphate acyltransferase (DHAP-AT), a peroxisomal enzyme catalyzing the first step in the synthesis of 22:6n-3-rich plasmalogens. To diminish the confounding effects of impaired plasmalogen synthesis in the brains of these Zellweger syndrome mouse models, kinetic experiments with labeled precursors, such as 18:3n-3 or 20:5n-3, in liver or isolated hepatocytes, which have negligible amounts of plasmalogens, are suggested to establish the rates of 22:6n-3 biosynthesis and precursor-product relationships. Similar experiments using brain of the acyl-CoA oxidase knockout mouse model are proposed to confirm the lack of peroxisomal beta -oxidation involvement in 22:6n-3 synthesis, since this mutation would not impair plasmalogen synthesis. (C) 2001 Academic Press.
引用
收藏
页码:1 / 7
页数:7
相关论文
共 50 条
[1]   A mouse model for Zellweger syndrome [J].
Baes, M ;
Gressens, P ;
Baumgart, E ;
Carmeliet, P ;
Casteels, M ;
Fransen, M ;
Evrard, P ;
Fahimi, D ;
Declercq, PE ;
Collen, D ;
vanVeldhoven, PP ;
Mannaerts, GP .
NATURE GENETICS, 1997, 17 (01) :49-57
[2]   DELTA-6 DESATURASE IN BRAIN AND LIVER DURING DEVELOPMENT AND AGING [J].
BOURRE, JM ;
PICIOTTI, M ;
DUMONT, O .
LIPIDS, 1990, 25 (06) :354-356
[3]  
BOWEN P, 1964, B JOHNS HOPKINS HOSP, V114, P402
[4]  
Carrié I, 2000, J LIPID RES, V41, P473
[5]   PEROXISOMAL BETA-OXIDATION OF POLYUNSATURATED LONG-CHAIN FATTY-ACIDS IN HUMAN FIBROBLASTS - THE POLYUNSATURATED AND THE SATURATED LONG-CHAIN FATTY-ACIDS ARE RETROCONVERTED BY THE SAME ACYL-COA OXIDASE [J].
CHRISTENSEN, E ;
WOLDSETH, B ;
HAGVE, TA ;
POLLTHE, BT ;
WANDERS, RJA ;
SPRECHER, H ;
STOKKE, O ;
CHRISTOPHERSEN, BO .
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1993, 53 :61-74
[6]   Phenotypes of patients with "simple" mendelian disorders are complex traits: Thresholds, modifiers, and systems dynamics [J].
Dipple, KM ;
McCabe, ERB .
AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 66 (06) :1729-1735
[7]   Hepatocellular and hepatic peroxisomal alterations in mice with a disrupted peroxisomal fatty acyl-coenzyme A oxidase gene [J].
Fan, CY ;
Pan, J ;
Chu, RY ;
Lee, D ;
Kluckman, KD ;
Usuda, N ;
Singh, I ;
Yeldandi, AV ;
Rao, MS ;
Maeda, N ;
Reddy, JK .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (40) :24698-24710
[8]   Targeted deletion of the PEX2 peroxisome assembly gene in mice provides a model for Zellweger syndrome, a human neuronal migration disorder [J].
Faust, PL ;
Hatten, ME .
JOURNAL OF CELL BIOLOGY, 1997, 139 (05) :1293-1305
[9]  
Gaposchkin DP, 1999, J LIPID RES, V40, P495
[10]   Dietary management of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (LCHADD). A case report and survey [J].
Gillingham, M ;
Van Calcar, S ;
Ney, D ;
Wolff, J ;
Harding, C .
JOURNAL OF INHERITED METABOLIC DISEASE, 1999, 22 (02) :123-131